1 Sjogren's Syndrome Treatment Drugs Market Overview
    1.1 Product Overview and Scope of Sjogren's Syndrome Treatment Drugs
    1.2 Sjogren's Syndrome Treatment Drugs Segment by Type
        1.2.1 Global Sjogren's Syndrome Treatment Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Plaquenil
        1.2.3 Methotrexate
        1.2.4 Duloxetine
        1.2.5 Others
    1.3 Sjogren's Syndrome Treatment Drugs Segment by Application
        1.3.1 Global Sjogren's Syndrome Treatment Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Pharmacy
        1.3.4 Other
    1.4 Global Sjogren's Syndrome Treatment Drugs Market Size Estimates and Forecasts
        1.4.1 Global Sjogren's Syndrome Treatment Drugs Revenue 2017-2028
        1.4.2 Global Sjogren's Syndrome Treatment Drugs Sales 2017-2028
        1.4.3 Sjogren's Syndrome Treatment Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Sjogren's Syndrome Treatment Drugs Market Competition by Manufacturers
    2.1 Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Sjogren's Syndrome Treatment Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Sjogren's Syndrome Treatment Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Sjogren's Syndrome Treatment Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Sjogren's Syndrome Treatment Drugs Market Competitive Situation and Trends
        2.5.1 Sjogren's Syndrome Treatment Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Sjogren's Syndrome Treatment Drugs Players Market Share by Revenue
        2.5.3 Global Sjogren's Syndrome Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sjogren's Syndrome Treatment Drugs Retrospective Market Scenario by Region
    3.1 Global Sjogren's Syndrome Treatment Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Sjogren's Syndrome Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Sjogren's Syndrome Treatment Drugs Market Facts & Figures by Country
        3.3.1 North America Sjogren's Syndrome Treatment Drugs Sales by Country
        3.3.2 North America Sjogren's Syndrome Treatment Drugs Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Sjogren's Syndrome Treatment Drugs Market Facts & Figures by Country
        3.4.1 Europe Sjogren's Syndrome Treatment Drugs Sales by Country
        3.4.2 Europe Sjogren's Syndrome Treatment Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Sjogren's Syndrome Treatment Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Sjogren's Syndrome Treatment Drugs Sales by Region
        3.5.2 Asia Pacific Sjogren's Syndrome Treatment Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Sjogren's Syndrome Treatment Drugs Market Facts & Figures by Country
        3.6.1 Latin America Sjogren's Syndrome Treatment Drugs Sales by Country
        3.6.2 Latin America Sjogren's Syndrome Treatment Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Sjogren's Syndrome Treatment Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Sjogren's Syndrome Treatment Drugs Sales by Country
        3.7.2 Middle East and Africa Sjogren's Syndrome Treatment Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Sjogren's Syndrome Treatment Drugs Historic Market Analysis by Type
    4.1 Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Sjogren's Syndrome Treatment Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Sjogren's Syndrome Treatment Drugs Price by Type (2017-2022)
5 Global Sjogren's Syndrome Treatment Drugs Historic Market Analysis by Application
    5.1 Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Sjogren's Syndrome Treatment Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Sjogren's Syndrome Treatment Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 Silvergate Pharmaceuticals
        6.2.1 Silvergate Pharmaceuticals Corporation Information
        6.2.2 Silvergate Pharmaceuticals Description and Business Overview
        6.2.3 Silvergate Pharmaceuticals Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Silvergate Pharmaceuticals Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.2.5 Silvergate Pharmaceuticals Recent Developments/Updates
    6.3 Novartis
        6.3.1 Novartis Corporation Information
        6.3.2 Novartis Description and Business Overview
        6.3.3 Novartis Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Novartis Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.3.5 Novartis Recent Developments/Updates
    6.4 Shanghai Zhongxisanwei
        6.4.1 Shanghai Zhongxisanwei Corporation Information
        6.4.2 Shanghai Zhongxisanwei Description and Business Overview
        6.4.3 Shanghai Zhongxisanwei Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Shanghai Zhongxisanwei Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.4.5 Shanghai Zhongxisanwei Recent Developments/Updates
    6.5 Eli Lilly
        6.5.1 Eli Lilly Corporation Information
        6.5.2 Eli Lilly Description and Business Overview
        6.5.3 Eli Lilly Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Eli Lilly Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.5.5 Eli Lilly Recent Developments/Updates
    6.6 Teva
        6.6.1 Teva Corporation Information
        6.6.2 Teva Description and Business Overview
        6.6.3 Teva Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Teva Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.6.5 Teva Recent Developments/Updates
    6.7 Zydus Cadila
        6.6.1 Zydus Cadila Corporation Information
        6.6.2 Zydus Cadila Description and Business Overview
        6.6.3 Zydus Cadila Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Zydus Cadila Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.7.5 Zydus Cadila Recent Developments/Updates
    6.8 Mylan
        6.8.1 Mylan Corporation Information
        6.8.2 Mylan Description and Business Overview
        6.8.3 Mylan Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Mylan Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.8.5 Mylan Recent Developments/Updates
    6.9 Apotex
        6.9.1 Apotex Corporation Information
        6.9.2 Apotex Description and Business Overview
        6.9.3 Apotex Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Apotex Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.9.5 Apotex Recent Developments/Updates
    6.10 Advanz Pharma
        6.10.1 Advanz Pharma Corporation Information
        6.10.2 Advanz Pharma Description and Business Overview
        6.10.3 Advanz Pharma Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Advanz Pharma Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.10.5 Advanz Pharma Recent Developments/Updates
    6.11 Sun Pharma
        6.11.1 Sun Pharma Corporation Information
        6.11.2 Sun Pharma Sjogren's Syndrome Treatment Drugs Description and Business Overview
        6.11.3 Sun Pharma Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Sun Pharma Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.11.5 Sun Pharma Recent Developments/Updates
    6.12 Kyung Poong
        6.12.1 Kyung Poong Corporation Information
        6.12.2 Kyung Poong Sjogren's Syndrome Treatment Drugs Description and Business Overview
        6.12.3 Kyung Poong Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Kyung Poong Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.12.5 Kyung Poong Recent Developments/Updates
    6.13 Ipca Laboratories
        6.13.1 Ipca Laboratories Corporation Information
        6.13.2 Ipca Laboratories Sjogren's Syndrome Treatment Drugs Description and Business Overview
        6.13.3 Ipca Laboratories Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Ipca Laboratories Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.13.5 Ipca Laboratories Recent Developments/Updates
    6.14 Hanlim Pharmaceutical
        6.14.1 Hanlim Pharmaceutical Corporation Information
        6.14.2 Hanlim Pharmaceutical Sjogren's Syndrome Treatment Drugs Description and Business Overview
        6.14.3 Hanlim Pharmaceutical Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Hanlim Pharmaceutical Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.14.5 Hanlim Pharmaceutical Recent Developments/Updates
    6.15 Bristol Laboratories
        6.15.1 Bristol Laboratories Corporation Information
        6.15.2 Bristol Laboratories Sjogren's Syndrome Treatment Drugs Description and Business Overview
        6.15.3 Bristol Laboratories Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Bristol Laboratories Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.15.5 Bristol Laboratories Recent Developments/Updates
    6.16 Lupin
        6.16.1 Lupin Corporation Information
        6.16.2 Lupin Sjogren's Syndrome Treatment Drugs Description and Business Overview
        6.16.3 Lupin Sjogren's Syndrome Treatment Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Lupin Sjogren's Syndrome Treatment Drugs Product Portfolio
        6.16.5 Lupin Recent Developments/Updates
7 Sjogren's Syndrome Treatment Drugs Manufacturing Cost Analysis
    7.1 Sjogren's Syndrome Treatment Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Sjogren's Syndrome Treatment Drugs
    7.4 Sjogren's Syndrome Treatment Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Sjogren's Syndrome Treatment Drugs Distributors List
    8.3 Sjogren's Syndrome Treatment Drugs Customers
9 Sjogren's Syndrome Treatment Drugs Market Dynamics
    9.1 Sjogren's Syndrome Treatment Drugs Industry Trends
    9.2 Sjogren's Syndrome Treatment Drugs Market Drivers
    9.3 Sjogren's Syndrome Treatment Drugs Market Challenges
    9.4 Sjogren's Syndrome Treatment Drugs Market Restraints
10 Global Market Forecast
    10.1 Sjogren's Syndrome Treatment Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Sjogren's Syndrome Treatment Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Sjogren's Syndrome Treatment Drugs by Type (2023-2028)
    10.2 Sjogren's Syndrome Treatment Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Sjogren's Syndrome Treatment Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Sjogren's Syndrome Treatment Drugs by Application (2023-2028)
    10.3 Sjogren's Syndrome Treatment Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Sjogren's Syndrome Treatment Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Sjogren's Syndrome Treatment Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Sjogren's Syndrome Treatment Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Sjogren's Syndrome Treatment Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Sjogren's Syndrome Treatment Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Sjogren's Syndrome Treatment Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Sjogren's Syndrome Treatment Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Sjogren's Syndrome Treatment Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Sjogren's Syndrome Treatment Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Sjogren's Syndrome Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Sjogren's Syndrome Treatment Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Sjogren's Syndrome Treatment Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Sjogren's Syndrome Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sjogren's Syndrome Treatment Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Sjogren's Syndrome Treatment Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Sjogren's Syndrome Treatment Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Sjogren's Syndrome Treatment Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Sjogren's Syndrome Treatment Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Sjogren's Syndrome Treatment Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Sjogren's Syndrome Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Sjogren's Syndrome Treatment Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Sjogren's Syndrome Treatment Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Sjogren's Syndrome Treatment Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Sjogren's Syndrome Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Sjogren's Syndrome Treatment Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Sjogren's Syndrome Treatment Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Sjogren's Syndrome Treatment Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Sjogren's Syndrome Treatment Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Sjogren's Syndrome Treatment Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Sjogren's Syndrome Treatment Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Sjogren's Syndrome Treatment Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Sjogren's Syndrome Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Sjogren's Syndrome Treatment Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Sjogren's Syndrome Treatment Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Sjogren's Syndrome Treatment Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Sjogren's Syndrome Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Sjogren's Syndrome Treatment Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Sjogren's Syndrome Treatment Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Sjogren's Syndrome Treatment Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Sjogren's Syndrome Treatment Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Sjogren's Syndrome Treatment Drugs Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Sjogren's Syndrome Treatment Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Sjogren's Syndrome Treatment Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Sjogren's Syndrome Treatment Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Sjogren's Syndrome Treatment Drugs Price by Application (2017-2022) & (US$/Unit)
    Table 49. Sanofi Corporation Information
    Table 50. Sanofi Description and Business Overview
    Table 51. Sanofi Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Sanofi Sjogren's Syndrome Treatment Drugs Product
    Table 53. Sanofi Recent Developments/Updates
    Table 54. Silvergate Pharmaceuticals Corporation Information
    Table 55. Silvergate Pharmaceuticals Description and Business Overview
    Table 56. Silvergate Pharmaceuticals Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Silvergate Pharmaceuticals Sjogren's Syndrome Treatment Drugs Product
    Table 58. Silvergate Pharmaceuticals Recent Developments/Updates
    Table 59. Novartis Corporation Information
    Table 60. Novartis Description and Business Overview
    Table 61. Novartis Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Novartis Sjogren's Syndrome Treatment Drugs Product
    Table 63. Novartis Recent Developments/Updates
    Table 64. Shanghai Zhongxisanwei Corporation Information
    Table 65. Shanghai Zhongxisanwei Description and Business Overview
    Table 66. Shanghai Zhongxisanwei Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Shanghai Zhongxisanwei Sjogren's Syndrome Treatment Drugs Product
    Table 68. Shanghai Zhongxisanwei Recent Developments/Updates
    Table 69. Eli Lilly Corporation Information
    Table 70. Eli Lilly Description and Business Overview
    Table 71. Eli Lilly Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Eli Lilly Sjogren's Syndrome Treatment Drugs Product
    Table 73. Eli Lilly Recent Developments/Updates
    Table 74. Teva Corporation Information
    Table 75. Teva Description and Business Overview
    Table 76. Teva Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Teva Sjogren's Syndrome Treatment Drugs Product
    Table 78. Teva Recent Developments/Updates
    Table 79. Zydus Cadila Corporation Information
    Table 80. Zydus Cadila Description and Business Overview
    Table 81. Zydus Cadila Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Zydus Cadila Sjogren's Syndrome Treatment Drugs Product
    Table 83. Zydus Cadila Recent Developments/Updates
    Table 84. Mylan Corporation Information
    Table 85. Mylan Description and Business Overview
    Table 86. Mylan Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Mylan Sjogren's Syndrome Treatment Drugs Product
    Table 88. Mylan Recent Developments/Updates
    Table 89. Apotex Corporation Information
    Table 90. Apotex Description and Business Overview
    Table 91. Apotex Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Apotex Sjogren's Syndrome Treatment Drugs Product
    Table 93. Apotex Recent Developments/Updates
    Table 94. Advanz Pharma Corporation Information
    Table 95. Advanz Pharma Description and Business Overview
    Table 96. Advanz Pharma Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Advanz Pharma Sjogren's Syndrome Treatment Drugs Product
    Table 98. Advanz Pharma Recent Developments/Updates
    Table 99. Sun Pharma Corporation Information
    Table 100. Sun Pharma Description and Business Overview
    Table 101. Sun Pharma Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Sun Pharma Sjogren's Syndrome Treatment Drugs Product
    Table 103. Sun Pharma Recent Developments/Updates
    Table 104. Kyung Poong Corporation Information
    Table 105. Kyung Poong Description and Business Overview
    Table 106. Kyung Poong Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Kyung Poong Sjogren's Syndrome Treatment Drugs Product
    Table 108. Kyung Poong Recent Developments/Updates
    Table 109. Ipca Laboratories Corporation Information
    Table 110. Ipca Laboratories Description and Business Overview
    Table 111. Ipca Laboratories Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Ipca Laboratories Sjogren's Syndrome Treatment Drugs Product
    Table 113. Ipca Laboratories Recent Developments/Updates
    Table 114. Hanlim Pharmaceutical Corporation Information
    Table 115. Hanlim Pharmaceutical Description and Business Overview
    Table 116. Hanlim Pharmaceutical Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Hanlim Pharmaceutical Sjogren's Syndrome Treatment Drugs Product
    Table 118. Hanlim Pharmaceutical Recent Developments/Updates
    Table 119. Bristol Laboratories Corporation Information
    Table 120. Bristol Laboratories Description and Business Overview
    Table 121. Bristol Laboratories Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Bristol Laboratories Sjogren's Syndrome Treatment Drugs Product
    Table 123. Bristol Laboratories Recent Developments/Updates
    Table 124. Lupin Corporation Information
    Table 125. Lupin Description and Business Overview
    Table 126. Lupin Sjogren's Syndrome Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Lupin Sjogren's Syndrome Treatment Drugs Product
    Table 128. Lupin Recent Developments/Updates
    Table 129. Production Base and Market Concentration Rate of Raw Material
    Table 130. Key Suppliers of Raw Materials
    Table 131. Sjogren's Syndrome Treatment Drugs Distributors List
    Table 132. Sjogren's Syndrome Treatment Drugs Customers List
    Table 133. Sjogren's Syndrome Treatment Drugs Market Trends
    Table 134. Sjogren's Syndrome Treatment Drugs Market Drivers
    Table 135. Sjogren's Syndrome Treatment Drugs Market Challenges
    Table 136. Sjogren's Syndrome Treatment Drugs Market Restraints
    Table 137. Global Sjogren's Syndrome Treatment Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 138. Global Sjogren's Syndrome Treatment Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 139. Global Sjogren's Syndrome Treatment Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 140. Global Sjogren's Syndrome Treatment Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 141. Global Sjogren's Syndrome Treatment Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 142. Global Sjogren's Syndrome Treatment Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 143. Global Sjogren's Syndrome Treatment Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 144. Global Sjogren's Syndrome Treatment Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 145. Global Sjogren's Syndrome Treatment Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 146. Global Sjogren's Syndrome Treatment Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 147. Global Sjogren's Syndrome Treatment Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 148. Global Sjogren's Syndrome Treatment Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Sjogren's Syndrome Treatment Drugs
    Figure 2. Global Sjogren's Syndrome Treatment Drugs Market Share by Type in 2021 & 2028
    Figure 3. Plaquenil Product Picture
    Figure 4. Methotrexate Product Picture
    Figure 5. Duloxetine Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Sjogren's Syndrome Treatment Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospital
    Figure 9. Pharmacy
    Figure 10. Other
    Figure 11. Global Sjogren's Syndrome Treatment Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Sjogren's Syndrome Treatment Drugs Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Sjogren's Syndrome Treatment Drugs Sales (2017-2028) & (K Units)
    Figure 14. Sjogren's Syndrome Treatment Drugs Sales Share by Manufacturers in 2021
    Figure 15. Global Sjogren's Syndrome Treatment Drugs Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Sjogren's Syndrome Treatment Drugs Players: Market Share by Revenue in 2021
    Figure 17. Sjogren's Syndrome Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Region (2017-2022)
    Figure 19. Global Sjogren's Syndrome Treatment Drugs Sales Market Share by Region in 2021
    Figure 20. Global Sjogren's Syndrome Treatment Drugs Revenue Market Share by Region (2017-2022)
    Figure 21. Global Sjogren's Syndrome Treatment Drugs Revenue Market Share by Region in 2021
    Figure 22. United States Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Sjogren's Syndrome Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Sjogren's Syndrome Treatment Drugs by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Sjogren's Syndrome Treatment Drugs
    Figure 46. Manufacturing Process Analysis of Sjogren's Syndrome Treatment Drugs
    Figure 47. Sjogren's Syndrome Treatment Drugs Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed